Sequential therapy comprising a 20(S)-camptothecin and a pyrimidine base analog
AssigneeSuperGen, Inc.
InventorsJoseph Rubinfeld, Karl L. Mettinger, John Lyons, Lawrence A. Romel
Life of this patent
Estimating the term…
Abstract
A method is provided for treating a patient having a disease associated with undesirable or uncontrolled cell proliferation, the method comprising: administering to the patient a 20(S)-camptothecin for a period of time during which a pyrimidine base analog is not being administered to the patient; and administering a pyrimidine base analog to the patient.
Claims53
A method for treating a patient having a disease associated with undesirable or uncontrolled cell proliferation, the method comprising:
- administering to the patient a 20(S)-camptothecin for a period of time during which a pyrimidine base analog is not being administered to the patient;
- and
- administering a pyrimidine base analog to the patient.
A method for treating a patient having a disease associated with undesirable or uncontrolled cell proliferation, the method comprising:
- administering to the patient a 20(S)-camptothecin for a period of time during which a pyrimidine base analog is not present in a pharmacologically active form in the patient's body;
- and administering a pyrimidine base analog to the patient.
Dependencies are inferred from the claim text.